Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 14/20 | 0.64 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.64 |
| ▸ | CCKAR | P32238 | 1/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.60 |
| ▸ | NPBWR1 | P48145 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30881872 | 0.98 | CCKBR (0.67) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL30274526 | 0.94 | CCKBR (0.62) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL31670335 | 0.92 | CCKBR (0.66) | CCKBROPRD1CCKAROPRM1 | |
| SCHEMBL30274515 | 0.92 | CCKBR (0.70) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL30209628 | 0.89 | CCKBR (0.68) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL29593980 | 0.87 | OPRD1 (0.68) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL30887560 | 0.87 | CCKBR (0.68) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL29505141 | 0.86 | OPRD1 (0.65) | CCKBROPRD1CCKAROPRM1NPBWR1 | |
| SCHEMBL29993941 | 0.86 | OPRD1 (0.61) | CCKBROPRD1CCKAROPRM1 | |
| SCHEMBL11659149 | 0.86 | CCKBR (0.68) | CCKBROPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117999277-A | Bionic peptides and their use in bone regeneration | 西尔克生物材料有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117999277-A | Bionic peptides and their use in bone regeneration | 西尔克生物材料有限公司 | 2024-05-07 | — | — | CN | disclosed |